newsfilter
← Latest News
Earnings Call Transcripts·

STEPHENS ANNUAL INVESTMENT CONFERENCE | NASH2026 - ADDUS HOMECARE CORP

  • Explicit Guidance:

    • Revenue Growth: Expects long-term organic growth of 3–5% for Personal Care Services (PCS). Forecasts Home Health to achieve mid-single-digit organic growth in FY2027 and beyond, driven by a 2.4% national Medicare rate increase and volume recovery.
    • Margin/OpEx: Anticipates Hospice margins to stabilize in the mid-to-high single digits; margin expansion expected in Home Health as the segment scales and right-sizes operations.
    • Acquisition Financials: The AccentCare transaction is expected to add approximately $280 million in annual revenue upon closing.
    • Balance Sheet: Plans to maintain leverage at approximately 1.0x even after the AccentCare closing, preserving debt capacity for future larger transactions in 2027.
    • Operational Targets: Aims to increase PCS fill rates from the mid-80s to the upper-80s range over the next 12–18 months. Targets a hiring volume of 103 to 110 hires per business day to maintain growth amidst ~50% turnover.
  • Business-Segment Outlook:

    • Personal Care Services (PCS): Long-term strategy to shift from pure labor arbitrage to value-based care by leveraging non-clinical access (2–4 hours/week) to identify clinical needs. Expecting continued volume growth driven by technology-enabled scheduling efficiency.
    • Home Health: Post-2026, the segment is transitioning from margin recovery to volume growth, targeting mid-single-digit organic growth. Currently operating in three primary states with potential for expansion.
    • Hospice: Returning to stability with normalized length of stay (>100 days) and median LOS in the mid-to-upper 20-day range. Expects consistent 2–3% annual CMS rate increases. Seeking rationalized valuation (lower double-digit to single-digit multiples) before resuming pure-play acquisitions.
    • Clinical Services Mix: Currently at ~18% of total revenue; strategic goal to increase clinical service mix to 25–30% by 2027 by supplementing PCS with clinical assets (e.g., RNs) and acquiring clinical capabilities.
  • Market and Competitive Outlook:

    • Demand Trends: Anticipates positive census growth trajectory as the company shifts focus from low-hour (<10 hours/month) respite patients to higher-hour clients (50–70 hours/month) to optimize caregiver utilization.
    • Competitive Landscape: PCS market fill-rate competition driven by caregiver supply; company expects to gain share by offering higher hourly volumes to caregivers via the "Addis Connect" app.
    • Market Share: Expecting to expand in Texas following the shift to Democratic leadership, potentially unlocking new rate increases and utilizing state rainy day funds to benefit the elderly/disabled population.
    • Reimbursement Shifts: Maintaining a strategic preference for episodic reimbursement models over per-visit structures with Medicare Advantage (MA) plans, though per-visit remains relevant for specific profitable cases.
  • Macro / Industry Outlook:

    • Regulatory Environment: Views the recent Democratic election results as a positive shift for Medicaid, potentially eliminating or deferring work requirements and increasing funding for low-income benefits.
    • Rate Dynamics: Expects continued state-level Medicaid rate increases (e.g., Illinois, Texas) and stable 2–3% CMS hospice/home health rate hikes.
    • Seasonality: Fourth-quarter census growth may be muted due to holiday periods affecting new patient authorizations, though year-over-year growth is expected to remain stable.
    • Policy Risks: Previously monitored OB-3 Medicaid cuts and work requirements; currently assessing these as neutral or slightly positive (tailwind for hiring in some contexts, though no immediate influx of workforce observed).
  • Strategic Initiatives:

    • M&A Pipeline: Closing of AccentCare transaction expected in Q1 2027 (specifically February). Actively scouting 2–3 additional PCS and clinical service targets for 2027.
    • Technology Integration: Accelerating migration of Personal Care systems to a "Home Care Home Base" platform; targeting 100% conversion by end of 2027 (including Gentiva/AccentCare assets) to enable data mining for care continuum bridging.
    • Value-Based Care: Expanding "Bridge Programs" in New Mexico, Texas, and Illinois to reduce hospital readmissions and ER visits, using PCS as the entry point to upsell clinical services.
    • Capacity Expansion: Utilizing proprietary scheduling app to increase caregiver utilization and fill rates, directly impacting bottom-line efficiency.
  • Risks and Headwinds to Outlook:

    • Acquisition Timing: Closing of AccentCare remains pending additional regulatory approvals despite passing antitrust review.
    • Valuation Constraints: Current multiples for pure-play hospice assets remain high (mid-teens), limiting near-term deal execution until rationalization occurs.
    • Staffing Supply: Continued reliance on high hiring volumes (100+ daily) to offset industry-standard turnover; growth is capped by caregiver availability rather than patient demand.
    • State-Specific Reimbursement: Uncertainty remains regarding the impact of Texas's new Democratic leadership on future rate increases, despite expectations of a favorable outcome.
    • Seasonality: Q4 census growth could lag due to administrative delays in state authorizations during holiday months.
  • Management Tone on the Future:

    • Confidence: High confidence in 2027, describing it as a "good year" driven by both organic improvements and M&A execution.
    • Strategic Clarity: Management is shifting focus from "survival/margin recovery" (Home Health) to "growth/scaling," emphasizing the unique ability to leverage a large PCS base to drive clinical referrals.
    • Execution: Expresses optimism that the "Addis Connect" technology rollout will materially improve fill rates and operational efficiency over the next 24–36 months.
    • Differentiation: Views the integration of PCS and clinical data as the most underappreciated earnings driver, enabling proactive care management that competitors cannot easily replicate.
  • Miscellaneous:

    • Timeframe for Tech Conversion: 100% migration to unified home care platform targeted for end of 2027.
    • Benchmarking: Company turnover rate of ~50% is superior to the industry average of ~65%.
    • Referral Sources: Hospice ADC (Average Daily Census) exceeds 4,100, with stable growth driven by targeted referral partnerships.
Company
ADDUS HOMECARE CORP
Keywords
ADDUS HOMECARE CORP